ADMA Biologics, Inc. (ADMA)
20.39
+0.41
(+2.05%)
USD |
NASDAQ |
Dec 11, 16:00
20.39
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Cash from Investing (Quarterly): -14.37M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Vanda Pharmaceuticals, Inc. | 21.36M |
| Aldeyra Therapeutics, Inc. | 25.00M |
| Arcutis Biotherapeutics, Inc. | -25.25M |
| Exelixis, Inc. | 25.40M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 13.29M |
| Cash from Financing (Quarterly) | -27.82M |
| Free Cash Flow | 40.61M |
| Free Cash Flow Per Share (Quarterly) | -0.0044 |
| Free Cash Flow to Equity (Quarterly) | -0.373M |
| Free Cash Flow to Firm (Quarterly) | 0.2092M |
| Free Cash Flow Yield | 0.81% |